Brevan Howard Capital Management LP
Q4 2023 13F-HR Holdings
Net value change ($000)
+422,337
(5.4%)
New positions
718
Sold out positions
84
Turnover %
66.4%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q3 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| EMB | 98,652 | 1138.5% |
| HYG | 38,695 | NEW |
| QQQ | 24,820 | NEW |
| HD | 15,157 | 963.6% |
| SPIB | 11,491 | NEW |
| NVDA | 9,683 | 743.1% |
| LQD | 8,631 | NEW |
| AAPL | 8,084 | 634.5% |
| SPLUNK INC | 8,057 | NEW |
| AHC | 6,214 | 1458.7% |
Top Reduces (Value $000, Stocks/ETFs)
| EWZ | -28,755 | -88.9% |
| CME | -20,533 | -100.0% |
| MRNA | -16,217 | -100.0% |
| XLF | -12,432 | -100.0% |
| VMWA | -6,852 | -100.0% |
| AIY | -6,416 | -100.0% |
| Seagen Inc. | -5,822 | -100.0% |
| Horizon Therapeutics Public Ltd Co | -5,206 | -100.0% |
| EEM | -1,762 | -42.2% |
| GDXJ | -1,726 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
7,188,573
(87.8% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|